Funding cuts are the single biggest threat to drug treatment recovery outcomes, a report published by the ACMD has warned
Bibliography: Interventions – Treatment
Mapping the Maze (PDF)
Services for women experiencing multiple disadvantage in England and Wales (agenda)
Hepatitis C Screening (PDF)
National Clinical Guideline (Irish Government)
3.1.4 People who use unprescribed or illicit drugs
3.1.5 Prisoners
3.1.6 People who are homeless
Interim report prepared by White House Commission on Combating Drug Addiction and the Opioid Crisis
Recommendations for action (White House)
Pain Management and the Opioid Epidemic: Balancing Societal and Individual Benefits and Risks of Prescription Opioid Use
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States (National Academy of Sciences.)
Hepatitis C in England and the UK
Latest hepatitis C virus (HCV) reports, slide sets and infographics for England and the UK (Public Health England)
Better care for people with co-occurring mental health and alcohol/drug use conditions (PDF)
A guide for commissioners and service providers (Public Health England)
Drug misuse and dependence: UK guidelines on clinical management
Often called the Orange Book, this is guidance for clinicians treating people with drug problems (DoH, UK)
Reducing Harm, Supporting Recovery 2017 – 2025
Ireland’s “Reducing Harm, Supporting Recovery” strategy sets out the Government’s response to addressing the harm caused by substance misuse in our society over the next eight years. It identifies a set of key actions to be delivered between 2017 and 2020, and provides an opportunity for the development of further actions from 2021 to 2024 to address needs that may emerge later on in the lifetime of the strategy (DoH, Ireland)
2017 Drug Strategy (PDF)
This Strategy sets out clear expectations for action from a wide range of partners, including those in education, health, safeguarding, criminal justice, housing and employment (Home Office)
A Performance Measurement Framework for Drug and Alcohol Task Forces (PDF)
The development of a Performance Measurement Framework for DATFs follows the review undertaken by the Department of Health in 20121 and adopts a similar logic to the Healthy Ireland strategy. Rather than looking at interventions in terms of inputs and outputs, the overriding concern is with the net effect of public policies at the population level. This is the only way of conceptualising effectiveness in an evidence-based and sustainable manner (Drugs and Alcohol Ireland)
Mental health in prisons
Improving the mental health of those in prison will require a step change in effort and resources (National Audit Office)
Alcohol and other drug treatment services in Australia 2015–16
In 2015–16, about 796 alcohol and other drug treatment services provided just over 206,600 treatment episodes to an estimated 134,000 clients (AIHW)
The Right Turn Veteran-Specific Recovery Service Evaluation (PDF)
Each year roughly 17,000 people leave the UK Armed Forces and the vast majority make a successful transition into civilian society. A small but increasing number of ex-forces personnel however experience poor physical and mental health, substance misuse and/or come into contact with the criminal justice sector. Poor transition is estimated to have cost the UK £98 million in 2015 alone (Sheffield Hallam University)
Evidence-based interventions for managing illicit drug dependence
Medical professionals have a key role to play in managing the harms (see Box 1) associated with illicit drug dependence (BMA)
An Overview of the Nation’s Behavioral Health
The Barometer is a unique compilation of facts and figures on issues such as substance use, serious mental illness, serious thoughts of suicide, and related treatment. The findings are broken down into major groups according to age, gender, racial and ethnic categories, income, and access to health insurance (SAMHSA)
Drug treatment in Ireland 2009-2015.
In this seven-year period 61,439 cases were treated for problem drug use (excluding alcohol). The number of cases rose from 7,479 in 2009 to 9,892 in 2015 (HRB)
Australian methamphetamine user outcomes (PDF)
This paper examines the demographics of methamphetamine users and their employment, education and health outcomes using data from the National Drug Strategy Household Survey, the Drug Use Monitoring in Australia program, the Alcohol and Other Drug Treatment Services data collection and the National Prisoner Health Data Collection (Australian Institute of Criminology)
Novel Psychoactive Substances synthetic cannabinoids in prison and community including best practice treatment approaches
The use of new psychoactive substances [NPS] in prisons has been recognised as an increasing problem for several years. Successive Chief Inspectors of Prisons and the Prisons and Probation Ombudsman have drawn attention to the impact on prisons, prison staff and prisoners themselves from the use of NPS (SMMGP)
Best practice portal
The relaunched Best practice portal is designed to help you find practical and reliable information on what works (and what doesn’t) in the areas of prevention, treatment, harm reduction and social reintegration (EMCDDA)
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 11
- Next Page »
